Schlumberger, Martin

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid®

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 16,535

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer

Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 6,707

Cabozantinib in Progressive Medullary Thyroid Cancer

Elisei, R., Schlumberger, M. J., Müller, S. P., Schöffski, P., Brose, M. S., Shah, M. H., Licitra, L., Jarzab, B., Medvedev, V., Kreissl, M. C., et al. (2013) · Journal of Clinical Oncology

Thyroid Cancer Diagnosis and TreatmentRenal cell carcinoma treatment

Cited by 1,217

Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

Sherman, S. I., Wirth, L. J., Droz, J.-P., Hofmann, M., Bastholt, L., Martins, R. G., Licitra, L., Eschenberg, M. J., Sun, Y.-N., Juan, T., et al. (2008) · New England Journal of Medicine

Thyroid Cancer Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 470

Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer

Schlumberger, M. J., Elisei, R., Bastholt, L., Wirth, L. J., Martins, R. G., Locati, L. D., Jarzab, B., Pacini, F., Daumerie, C., Droz, J.-P., et al. (2009) · Journal of Clinical Oncology

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 340

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence

Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene

Telomeres, Telomerase, and SenescenceRedox biology and oxidative stress

Cited by 285

Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients

Baudin, E., Cao, C. D., Cailleux, A. F., Leboulleux, S., Travagli, J. P., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 278

Prognostic parameters of metastatic adrenocortical carcinoma

Assié, G., Antoni, G., Tissier, F., Caillou, B., Abiven, G., Gicquel, C., Leboulleux, S., Travagli, J.-P., Dromain, C., Bertagna, X., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 236

Subclinical hyperthyroidism: clinical features and treatment options

Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 217

Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study

Hermsen, I. G., Fassnacht, M., Terzolo, M., Houterman, S., den Hartigh, J., Leboulleux, S., Daffara, F., Berruti, A., Chadarevian, R., Schlumberger, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 173

New therapeutic approaches for metastatic thyroid carcinoma

Baudin, E., & Schlumberger, M. (2007) · The Lancet Oncology

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 143

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

Leboulleux, S., Deandreis, D., Al Ghuzlan, A., Aupérin, A., Goéré, D., Dromain, C., Elias, D., Caillou, B., Travagli, J. P., De Baere, T., et al. (2010) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 133

Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane”

Fortunato, R. S., Lima de Souza, E. C., Hassani, R. A.-E., Boufraqech, M., Weyemi, U., Talbot, M., Lagente-Chevallier, O., de Carvalho, D. P., Bidart, J.-M., Schlumberger, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsRedox biology and oxidative stress

Cited by 88

Immunotherapy-induced Addison’s disease: a rare, persistent and potentially lethal side-effect

Hescot, S., Haissaguerre, M., Pautier, P., Kuhn, E., Schlumberger, M., & Berdelou, A. (2018) · European Journal of Cancer

Adrenal Hormones and DisordersCancer Immunotherapy and Biomarkers

Cited by 31

Type 2 deiodinase Thr92Ala polymorphism and aging are associated with a decreased pituitary sensitivity to thyroid hormone

Luongo, C., De Stefano, M. A., Ambrosio, R., Volpe, F., Porcelli, T., Golia, V., Bellevicine, C., Troncone, G., Masone, S., Damiano, V., et al. (2023) · Thyroid

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 11